Veradermics is trading 4.65% down at $99.00 as broader markets weakened amid surging oil prices and escalating U.S.-Iran geopolitical tensions.

  • The Dow, S&P 500, and Nasdaq are also lower, supporting a global risk-off explanation.
  • Veradermics is scheduled to present at Citi’s Biopharma Back to School Conference at 3:00 p.m. ET on September 9, 2026; no company-specific negative catalyst has been reported.